Summary
Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Both are often discussed in Neurology and brain health contexts, while Humanin is more of a mitochondrial peptide and Selank is better described as a immune-modulating peptide. Mechanistically, both point toward Signaling modulator and converge on GPCR receptor, although the downstream emphasis is not identical. Humanin has a more mitochondrial-encoded origin, while Selank is closer to synthetic analog background with Humanin in Preclinical development and Selank approved for Research use only. Their sequence patterns also diverge, with Humanin showing alpha-helical domain features and Selank showing proline-rich features.